Ch27.pdf

(446 KB) Pobierz
27
CHAPTER
Alterations in
Gastrointestinal Function
Alterations in Intestinal Absorption
Malabsorption Syndrome
Neoplasms
Adenomatous Polyps
Colorectal Cancer
Disorders of the Esophagus
Dysphagia
Esophageal Diverticulum
Gastroesophageal Reflux Disease
Gastroesophageal Reflux in Children
Cancer of the Esophagus
Disorders of the Stomach
Gastric Mucosal Barrier
Gastritis
Acute Gastritis
Chronic Gastritis
Ulcer Disease
Peptic Ulcer Disease
Zollinger-Ellison Syndrome
Stress Ulcers
Cancer of the Stomach
Disorders of the Small and Large Intestines
Irritable Bowel Syndrome
Inflammatory Bowel Disease
Crohn’s Disease
Ulcerative Colitis
Infectious Colitis
Clostridium Difficile Colitis
Escherichia Coli O157:H7 Infection
Diverticular Disease
Appendicitis
Alterations in Intestinal Motility
Diarrhea
Constipation
Intestinal Obstruction
Peritonitis
G astrointestinal disorders are not cited as the leading
cause of death in the United States, nor do they receive
the same publicity as heart disease and cancer. However,
according to government reports, digestive diseases rank third
in the total economic burden of illness, resulting in consider-
able human suffering, personal expenditures for treatment, lost
working hours, and a drain on the nation’s economy. It has
been estimated that 60 to 70 million Americans have digestive
disease. 1 Even more important is the fact that proper nutrition
or a change in health practices could prevent or minimize
many of these disorders.
DISORDERS OF THE ESOPHAGUS
The esophagus is a tube that connects the oropharynx with the
stomach. It lies posterior to the trachea and larynx and extends
through the mediastinum, intersecting the diaphragm at the
level of the 11th thoracic vertebra. The esophagus functions
primarily as a conduit for passage of food from the pharynx to
the stomach, and the structure of its wall is designed for this
purpose: the smooth muscle layers provide the peristaltic
movements needed to move food along its length, and the epi-
thelial layer secretes mucus, which protects its surface and aids
in lubricating food.
Dysphagia
The act of swallowing depends on the coordinated action of the
tongue and pharynx. These structures are innervated by cranial
nerves V, IX, X, and XII. Dysphagia refers to difficulty in swal-
lowing. If swallowing is painful, it is referred to as odynophagia .
Dysphagia can result from altered nerve function or from dis-
orders that produce narrowing of the esophagus. Lesions of the
central nervous system (CNS), such as a stroke, often involve
473
746442534.082.png 746442534.093.png 746442534.104.png 746442534.115.png 746442534.001.png 746442534.012.png 746442534.023.png 746442534.034.png 746442534.039.png 746442534.040.png 746442534.041.png 746442534.042.png 746442534.043.png 746442534.044.png 746442534.045.png 746442534.046.png 746442534.047.png 746442534.048.png 746442534.049.png 746442534.050.png 746442534.051.png 746442534.052.png 746442534.053.png 746442534.054.png 746442534.055.png 746442534.056.png 746442534.057.png 746442534.058.png 746442534.059.png 746442534.060.png 746442534.061.png 746442534.062.png 746442534.063.png 746442534.064.png
 
474
Unit Seven: Alterations in the Gastrointestinal System
the cranial nerves that control swallowing. Strictures and can-
cer of the esophagus and strictures resulting from scarring can
reduce the size of the esophageal lumen and make swallowing
difficult. Scleroderma, an autoimmune disease that causes fi-
brous replacement of tissues in the muscularis layer of the
gastrointestinal tract, is another important cause of dysphagia. 2
Persons with dysphagia usually report choking, coughing, or an
abnormal sensation of food sticking in the back of the throat
or upper chest when they swallow.
In a condition called achalasia , the lower esophageal sphinc-
ter fails to relax; food that has been swallowed has difficulty
passing into the stomach, and the esophagus above the lower
esophageal sphincter becomes enlarged. One or several meals
may lodge in the esophagus and pass slowly into the stomach.
There is danger of aspiration of esophageal contents into the
lungs when the person lies down.
4.0) are
particularly damaging. There is controversy regarding the im-
portance of hiatal hernia ( i.e. , herniation of the stomach
through an enlarged hiatus in the diaphragm) in the patho-
genesis of reflux disease. Small hiatal hernias are common
and considered to be of no significance in asymptomatic people.
However, in cases of severe erosive esophagitis where gastro-
esophageal reflux and large hiatal hernia coexist, the hernia
may retard esophageal acid clearance and contribute to the
disorder. 3,5
Reflux esophagitis involves mucosal injury to the esopha-
gus, hyperemia, and inflammation. The most common symp-
tom of gastroesophageal reflux is heartburn. It frequently is
severe, occurring 30 to 60 minutes after eating. It often is made
worse by bending at the waist and recumbency and usually is
relieved by sitting upright. The severity of heartburn is not in-
dicative of the extent of mucosal injury; only a small percent-
age of people who report heartburn have mucosal injury.
Often, the heartburn occurs during the night. Antacids give
prompt, although transient relief. Other symptoms include
belching and chest pain. The pain usually is located in the epi-
gastric or retrosternal area and often radiates to the throat,
shoulder, or back. Because of its location, the pain may be
confused with angina. The reflux of gastric contents also may
produce respiratory symptoms such as wheezing, chronic
cough, and hoarseness. There is considerable evidence link-
ing gastroesophageal reflux with bronchial asthma. 7 The pro-
posed mechanisms of reflux-associated asthma and chronic
cough include aspiration, laryngeal injury, and vagal-mediated
bronchospasm.
Persistent gastroesophageal reflux produces a cycle of mu-
cosal damage that predisposes to strictures and a condition
called Barrett’s esophagus . Strictures are caused by a combina-
tion of scar tissue, spasm, and edema. They produce narrowing
of the esophagus and can cause dysphagia. Barrett’s esophagus
is characterized by a reparative process in which the squamous
mucosa that normally lines the esophagus gradually is replaced
by columnar epithelium resembling that in the stomach or in-
testines. 5,6 It is associated with increased risk for development
of esophageal cancer.
The diagnosis of gastroesophageal reflux depends on a his-
tory of reflux symptoms and selective use of diagnostic meth-
ods, including radiographic studies using a contrast medium
such as barium, esophagoscopy, and ambulatory esophageal
pH monitoring. 8
The treatment of gastroesophageal reflux usually focuses
on conservative measures. These measures include avoidance
of positions and conditions that increase gastric reflux. 8
Avoidance of large meals and foods that reduce lower eso-
phageal sphincter tone ( e.g. , caffeine, fats, chocolate), alcohol,
and smoking is recommended. Sleeping with the head elevated
helps to prevent reflux during the night. Weight loss usually is
recommended in overweight people.
Antacids or a combination of antacids and alginic acid also
are recommended for mild disease. Alginic acid produces a
foam when it comes in contact with gastric acid; if reflux oc-
curs, the foam, rather than acid, rises into the esophagus.
Histamine type 2 receptor-blocking drugs, which inhibit gas-
tric acid production, often are recommended when additional
treatment is needed. Proton pump inhibitors, which block the
final pathway for acid secretion, may be used for persons who
in contact with mucosa. Acidic gastric fluids (pH
<
Esophageal Diverticulum
A diverticulum of the esophagus is an outpouching of the
esophageal wall caused by a weakness of the muscularis layer.
An esophageal diverticulum tends to retain food. Reports that
the food stops before it reaches the stomach are common, as
are reports of gurgling, belching, coughing, and foul-smelling
breath. The trapped food may cause esophagitis and ulceration.
Because the condition usually is progressive, correction of the
defect requires surgical intervention.
Gastroesophageal Reflux Disease
The term reflux refers to backward or return movement. In the
context of gastroesophageal reflux, it refers to the backward
movement of gastric contents into the esophagus, a condition
that causes heartburn. Often referred to as gastroesophageal
reflux disease (GERD), it probably is the most common dis-
order originating in the gastrointestinal tract. Most persons
experience heartburn occasionally as a result of reflux. Such
symptoms usually occur soon after eating, are short lived, and
seldom cause more serious problems. However, for some
persons, persistent heartburn can represent reflux disease with
esophagitis.
The lower esophageal sphincter regulates the flow of food
from the esophagus into the stomach. Both internal and exter-
nal mechanisms function in maintaining the antireflux func-
tion of the lower esophageal sphincter. 3,4 Relaxation of the
lower esophageal sphincter is a brain stem reflex that is medi-
ated by the vagus nerve in response to a number of afferent
stimuli. Transient relaxation with reflux is common after
meals. Gastric distension and meals high in fat increase the fre-
quency of relaxation. Refluxed material normally is returned to
the stomach by secondary peristaltic waves in the esophagus,
with swallowed saliva neutralizing and washing away the re-
fluxed acid.
GERD is thought to be associated with a weak or incom-
petent lower esophageal sphincter that allows reflux to occur,
the irritant effects of the refluxate, and decreased clearance of
the refluxed acid from the esophagus after it has occurred. 5,6
Delayed gastric emptying also may contribute to reflux by
increasing gastric volume and pressure with greater chance
for reflux. Esophageal mucosal injury is related to the de-
structive nature of the refluxate and the amount of time it is
 
475
Chapter 27: Alterations in Gastrointestinal Function
continue to have daytime symptoms, recurrent strictures, or
large esophageal ulcerations. Surgical treatment may be indi-
cated in some people.
reflux, decrease crying and energy expenditure, and increase the
calorie density of the formula. 9,10 In infants, positioning on the
left side seems to decrease reflux. In older infants and children,
raising the head of the bed and keeping the child upright may
help. Medications usually are not added to the treatment regi-
men until pathologic reflux has been documented by diagnos-
tic testing.
Gastroesophageal Reflux in Children
Gastroesophageal reflux is a common problem in infants. The
small reservoir capacity of an infant’s esophagus coupled with
frequent spontaneous reductions in sphincter pressure con-
tributes to reflux. Regurgitation of at least one episode a day
occurs in as many as half of infants 0 to 3 months of age. By
6 months of age it becomes less frequent, and it abates by
2 years of age as the child assumes a more upright posture and
eats solid foods. 9,10 Although many infants have minor degrees
of reflux, complications occur in 1 of every 300 to 500 chil-
dren. 9,10 The condition occurs more frequently in children with
cerebral palsy, Down’s syndrome, and other causes of devel-
opmental delay.
In most cases, infants with simple reflux are thriving and
healthy, and symptoms resolve between 9 and 24 months of
age. Pathologic reflux is classified into three categories: (1) re-
gurgitation and malnutrition, (2) esophagitis, and (3) respira-
tory problems. Symptoms of esophagitis include evidence
of pain when swallowing, hematemesis, anemia caused by
esophageal bleeding, heartburn, irritability, and sudden or in-
consolable crying. Parents often report feeding problems in
their infants. 9 These infants often are irritable and demonstrate
early satiety. Sometimes the problems progress to actual resis-
tance to feeding. Tilting of the head to one side and arching of
the back may be noted in children with severe reflux. The head
positioning is thought to represent an attempt to protect the
airway or reduce the pain-associated reflux. Sometimes regur-
gitation is associated with dental caries and recurrent otalgia.
The ear pain is thought to occur through referral from the
vagus nerve in the esophagus to the ear. A variety of respira-
tory symptoms are caused by damage to the respiratory mu-
cosa when gastric reflux enters the esophagus. Reflux may
cause laryngospasm, apnea, and bradycardia. A relationship
between reflux and acute life-threatening events or sudden in-
fant death syndrome has been proposed. However, the associ-
ation remains a matter of controversy, and the linkage may be
coincidental. 9,10
Rumination is the repetitive gagging, regurgitation, mouth-
ing, and reswallowing of regurgitated material. Although the
cause of the disorder is unknown, it often is associated with
mental retardation or altered interaction with the environment
( e.g. , lack of stimulation in newborn intensive care units or be-
cause of altered relationships with caregivers). As with pure re-
flux, rumination may produce severe esophagitis with signs of
iron deficiency anemia, failure to thrive, and head tilting. 10
Diagnosis of gastroesophageal reflux in infants and chil-
dren often is based on parental and clinical observations. The
diagnosis may be confirmed by esophageal pH probe studies
or barium fluoroscopic esophagography. In severe cases, esoph-
agoscopy may be used to demonstrate reflux and obtain a
biopsy.
Various treatment methods are available for infants and
children with gastroesophageal reflux. Small, frequent feedings
are recommended because of the association between gastric
volume and transient relaxation of the esophagus. Thickening
an infant’s feedings with cereal tends to decrease the volume of
Cancer of the Esophagus
Carcinoma of the esophagus accounts for approximately 6% of
all gastrointestinal cancers. This disease is more common in
persons older than 50 years, with a male-to-female ratio of
approximately 2
1. 11
There are two types of esophageal cancers: squamous cell
and adenocarcinomas. Fewer than 50% of esophageal tumors
are squamous cell cancers. These cancers are associated more
commonly with dietary and environmental influences. 11,12
Most squamous cell cancers in the United States and Europe are
attributable to alcohol and tobacco use. Adenocarcinomas,
which typically arise from Barrett’s esophagus, account for
more than 50% of esophageal cancers. The incidence of this
type of cancer appears to be increasing. Adenocarcinomas typ-
ically are located in the distal esophagus and may invade the
adjacent upper part of the stomach. Endoscopic surveillance in
people with Barrett’s esophagus may detect adenocarcinoma at
an earlier stage, when it is more amenable to curative surgical
resection. 12
Dysphagia is by far the most frequent complaint of persons
with esophageal cancer. It is apparent first with ingestion of
bulky food, later with soft food, and finally with liquids. Un-
fortunately, it is a late manifestation of the disease. Weight loss,
anorexia, fatigue, and pain on swallowing also may occur.
Treatment includes surgical resection, which provides a
means of cure when done in early disease and palliation when
done in late disease. Irradiation is used as a palliative treat-
ment. Chemotherapy sometimes is used before surgery to de-
crease the size of the tumor, and it may be used along with
irradiation and surgery in an effort to increase survival. 12
The prognosis for persons with cancer of the esophagus,
although poor, has improved. However, even with modern
forms of therapy, the long-term survival is limited because, in
many cases, the disease has already metastasized by the time
the diagnosis is made.
In summary, the esophagus is a tube that connects the
oropharynx with the stomach; it functions primarily as a con-
duit for passage of food from the pharynx to the stomach.
Dysphagia refers to difficulty in swallowing; it can result from
altered nerve function or from disorders that produce narrow-
ing of the esophagus. A diverticulum of the esophagus is an
outpouching of the esophageal wall caused by a weakness of
the muscularis layer.
Gastrointestinal reflux refers to the backward movement
of gastric contents into the esophagus, a condition that
causes heartburn. Although most persons experience occa-
sional esophageal reflux and heartburn, persistent reflux can
cause esophagitis. Gastroesophageal reflux is a common
problem in infants. Reflux commonly corrects itself with age,
and symptoms abate in most children by 2 years of age.
746442534.065.png 746442534.066.png 746442534.067.png 746442534.068.png
 
476
Unit Seven: Alterations in the Gastrointestinal System
The gastric epithelial cells are connected by tight junctions
that prevent acid penetration, and they are covered with an im-
permeable hydrophobic lipid layer that prevents diffusion of
ionized water-soluble molecules. Aspirin, which is nonionized
and lipid soluble in acid solutions, rapidly diffuses across this
lipid layer, increasing mucosal permeability and damaging epi-
thelial cells. 14 Gastric irritation and occult bleeding caused by
gastric irritation occur in a significant number of persons who
take aspirin on a regular basis (Fig. 27-1). Alcohol, which also
is lipid soluble, disrupts the mucosal barrier; when aspirin and
alcohol are taken in combination, as they often are, there is in-
creased risk of gastric irritation. Bile acids also attack the lipid
components of the mucosal barrier and afford the potential for
gastric irritation when there is reflux of duodenal contents into
the stomach.
Normally, the secretion of hydrochloric acid by the parietal
cells of the stomach is accompanied by secretion of bicarbon-
ate ions (HCO 3 ). For every hydrogen ion (H + ) that is secreted,
a HCO 3 is produced, and as long as HCO 3 production is equal
to H + secretion, mucosal injury does not occur. Changes in
gastric blood flow, as in shock, tend to decrease HCO 3 pro-
duction. This is particularly true in situations in which de-
creased blood flow is accompanied by acidosis. Aspirin and the
nonsteroidal anti-inflammatory drugs (NSAIDs) also impair
HCO 3 secretion.
Prostaglandins, chemical messengers derived from cell mem-
brane lipids, play an important role in protecting the gastro-
intestinal mucosa from injury. The prostaglandins probably
exert their effect through improved blood flow, increased
bicarbonate ion secretion, and enhanced mucus production.
The fact that drugs such as aspirin and the NSAIDs inhibit
prostaglandin synthesis may contribute to their ability to pro-
duce gastric irritation. 14 Smoking and older age have been asso-
Although many infants have minor degrees of reflux, some in-
fants and small children have significant reflux that interferes
with feeding, causes esophagitis, and results in respiratory
symptoms and other complications.
Carcinoma of the esophagus, which accounts for 6% of all
cancers, is more common in persons older than 50 years, and
the male-to-female ratio is approximately 2:1. There are two
types of esophageal cancer: squamous cell and adenocarci-
noma. Most squamous cell cancers are attributable to alcohol
and tobacco use, whereas adenocarcinomas are more closely
linked to esophageal reflux and Barrett’s esophagus.
DISORDERS OF THE STOMACH
The stomach is a reservoir for contents entering the digestive
tract. While in the stomach, food is churned and mixed with
hydrochloric acid and pepsin before being released into the
small intestine. Normally, the mucosal surface of the stomach
provides a barrier that protects it from the hydrochloric acid
and pepsin contained in gastric secretions. Disorders of the
stomach include gastritis, peptic ulcer, and gastric carcinoma.
Gastric Mucosal Barrier
The stomach lining usually is impermeable to the acid it se-
cretes, a property that allows the stomach to contain acid and
pepsin without having its wall digested. Several factors con-
tribute to the protection of the gastric mucosa, including an im-
permeable epithelial cell surface covering, mechanisms for the
selective transport of hydrogen and bicarbonate ions, and the
characteristics of gastric mucus. 13 These mechanisms are col-
lectively referred to as the gastric mucosal barrier .
KEY CONCEPTS
DISRUPTION OF THE GASTRIC MUCOSA
AND ULCER DEVELOPMENT
The stomach is protected by tight cellular junctions,
a protective mucus layer, and prostaglandins that
serve as chemical messengers to protect the stom-
ach lining by improving blood flow, increasing bicar-
bonate secretion, and enhancing mucus production.
Two of the major causes of gastric irritation and
ulcer formation are aspirin or nonsteroidal anti-
inflammatory drugs (NSAIDs) and infection
with Helicobacter pylori .
Aspirin and NSAIDs exert their destructive effects by
damaging epithelial cells, impairing mucus produc-
tion, and inhibiting prostaglandin synthesis.
H. pylori is an infectious agent that thrives in the acid
environment of the stomach and disrupts the mu-
cosal barrier that protects the stomach from the
harmful effects of its digestive enzymes.
FIGURE 27-1 Erosive gastritis. This endoscopic view of the
stomach in a patient who was ingesting aspirin reveals acute he-
morrhagic lesions. (From Rubin E., Farber J.L. [1999]. Pathology
[3rd ed., p. 683]. Philadelphia: Lippincott Williams & Wilkins)
746442534.069.png 746442534.070.png 746442534.071.png 746442534.072.png 746442534.073.png 746442534.074.png 746442534.075.png 746442534.076.png 746442534.077.png 746442534.078.png 746442534.079.png 746442534.080.png 746442534.081.png 746442534.083.png 746442534.084.png 746442534.085.png 746442534.086.png 746442534.087.png 746442534.088.png 746442534.089.png 746442534.090.png 746442534.091.png 746442534.092.png 746442534.094.png 746442534.095.png 746442534.096.png 746442534.097.png 746442534.098.png 746442534.099.png 746442534.100.png 746442534.101.png 746442534.102.png 746442534.103.png 746442534.105.png 746442534.106.png 746442534.107.png 746442534.108.png 746442534.109.png 746442534.110.png 746442534.111.png 746442534.112.png 746442534.113.png 746442534.114.png 746442534.116.png 746442534.117.png 746442534.118.png 746442534.119.png 746442534.120.png 746442534.121.png 746442534.122.png 746442534.123.png 746442534.124.png 746442534.125.png 746442534.002.png 746442534.003.png 746442534.004.png 746442534.005.png 746442534.006.png 746442534.007.png 746442534.008.png 746442534.009.png 746442534.010.png 746442534.011.png 746442534.013.png 746442534.014.png 746442534.015.png 746442534.016.png 746442534.017.png 746442534.018.png 746442534.019.png 746442534.020.png 746442534.021.png 746442534.022.png 746442534.024.png 746442534.025.png 746442534.026.png 746442534.027.png 746442534.028.png 746442534.029.png 746442534.030.png 746442534.031.png 746442534.032.png 746442534.033.png 746442534.035.png
 
746442534.036.png
477
Chapter 27: Alterations in Gastrointestinal Function
ciated with reduced gastric and duodenal prostaglandin con-
centrations; these observations may explain the predisposition
to ulcer disease in smokers and older persons. 15
Chronic autoimmune gastritis and multifocal atrophic
gastritis cause few symptoms related directly to gastric changes.
Persons with autoimmune chronic gastritis may have signs of
pernicious anemia. More important is the development of pep-
tic ulcer and increased risk of peptic ulcer and gastric carcinoma.
Approximately 2% to 4% of persons with atrophic gastritis
eventually experience gastric carcinoma. 11
H. pylori gastritis is the most common type of chronic non-
erosive gastritis in the United States. H. pylori are small, curved,
gram-negative rods that can colonize the mucus-secreting
epithelial cells of the stomach 16,17 (Fig. 27-2). H. pylori have
multiple flagella, which allow them to move through the mu-
cous layer of the stomach, and they secrete urease, which en-
ables them to produce sufficient ammonia to buffer the acidity
of their immediate environment. Because the organism ad-
heres only to the mucus-secreting cells of the stomach, it does
not usually colonize other parts of the gastrointestinal tract.
H. pylori produce an enzyme that degrades mucin and has the
capacity to interfere with the local protection of the gastric mu-
cosa against acid. It also may produce toxins that directly dam-
age the mucosa and produce ulceration in other ways. Chronic
infection with H. pylori can lead to gastric atrophy and intesti-
nal metaplasia. H. pylori also can cause peptic ulcer (to be dis-
cussed) and has been linked to the development of gastric ade-
nocarcinoma.
Chemical gastropathy is a chronic gastric injury resulting from
reflux of alkaline duodenal contents, pancreatic secretions, and
bile into the stomach. It is most commonly seen in persons
who have had gastroduodenostomy or gastrojejunostomy
surgery. A milder form may occur in persons with gastric ulcer,
Gastritis
Gastritis refers to inflammation of the gastric mucosa. There are
many causes of gastritis, most of which can be grouped under
the headings of acute or chronic gastritis.
Acute Gastritis
Acute gastritis refers to a transient inflammation of the gastric
mucosa. It is most commonly associated with local irritants
such as bacterial endotoxins, caffeine, alcohol, and aspirin.
Depending on the severity of the disorder, the mucosal re-
sponse may vary from moderate edema and hyperemia to he-
morrhagic erosion of the gastric mucosa.
The complaints of persons with acute gastritis vary. Persons
with aspirin-related gastritis can be totally unaware of the con-
dition or may report only heartburn or sour stomach. Gastritis
associated with excessive alcohol consumption is a different sit-
uation; it often causes transient gastric distress, which may lead
to vomiting and, in more severe situations, to bleeding and
hematemesis. Gastritis caused by the toxins of infectious or-
ganisms, such as the staphylococcal enterotoxins, usually has
an abrupt and violent onset, with gastric distress and vomiting
ensuing approximately 5 hours after the ingestion of a contam-
inated food source. Acute gastritis usually is a self-limiting dis-
order; complete regeneration and healing usually occur within
several days.
Chronic Gastritis
Chronic gastritis is a separate entity from acute gastritis. It is
characterized by the absence of grossly visible erosions and the
presence of chronic inflammatory changes leading eventually
to atrophy of the glandular epithelium of the stomach. The
changes may become dysplastic and possibly transform into
carcinoma. Factors such as chronic alcohol abuse, cigarette
smoking, and chronic use of NSAIDs may contribute to the
development of the disease.
There are four major types of chronic gastritis: (1) auto-
immune gastritis, (2) multifocal atrophic gastritis, (3) Helicobac-
ter pylori gastritis, and (4) chemical gastropathy. 16 Autoimmune
gastritis is the least common form of chronic gastritis. Most per-
sons with the disorder have circulating antibodies to parietal
cells and intrinsic factor, so this form of chronic gastritis is con-
sidered to be of autoimmune origin. Autoimmune destruction
of the parietal cells leads to hypochlorhydria or achlorhydria,
a high intragastric pH, and hypergastrinemia. Pernicious ane-
mia is a megaloblastic anemia that is caused by malabsorption
of vitamin B 12 caused by a deficiency of intrinsic factor (see
Chapter 13). This type of chronic gastritis frequently is associ-
ated with other autoimmune disorders, such as Hashimoto’s
thyroiditis and Addison’s disease.
Multifocal atrophic gastritis is a disorder of unknown etiology.
It is more common than autoimmune gastritis and is seen
more frequently in whites than in other races. It is particularly
common in Asia, Scandinavia, and parts of Europe and Latin
America. As with autoimmune gastritis, it is associated with re-
duced gastric acid secretion, but achlorhydria and pernicious
anemia are less common.
FIGURE 27-2 Infective gastritis. H. pylori appears on silver stain-
ing as small, curved rods on the surface of the gastric mucosa.
(From Rubin E., Farber J.L. [1999]. Pathology [3rd ed., p. 687].
Philadelphia: Lippincott Williams & Wilkins)
746442534.037.png
 
746442534.038.png
Zgłoś jeśli naruszono regulamin